Affordable Access

Publisher Website

Effects of Medicare Part D on guideline-concordant pharmacotherapy for bipolar I disorder among dual beneficiaries.

Authors
Type
Published Article
Journal
Psychiatric services (Washington, D.C.)
Publication Date
Volume
65
Issue
3
Pages
323–329
Identifiers
DOI: 10.1176/appi.ps.201300123
PMID: 24337444
Source
Medline

Abstract

Increased receipt of guideline-concordant pharmacotherapy for bipolar I disorder may reflect relatively less restrictive management of antimanic medications under Part D. The clinical significance of the change is unclear, given the small effect sizes. However, increased emergency department visits merit attention for the Medicaid beneficiaries who continue to transition to Part D.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments